Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers

  Liver Diseases

  Free Subscription


4 Am J Gastroenterol
1 Am J Pathol
4 Biochem Biophys Res Commun
4 BMC Cancer
1 BMC Gastroenterol
1 Br J Surg
1 Cancer
3 Clin Res Hepatol Gastroenterol
2 Dig Dis Sci
5 Hepatology
2 Indian J Gastroenterol
1 J Clin Oncol
1 J Gastroenterol
1 J Hepatol
1 J Pediatr
2 J Pediatr Surg
2 Lancet
2 Oncogene
2 PLoS One
1 Radiol Imaging Cancer
4 Radiology
1 Semin Liver Dis

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Gastroenterol

  1. WANG B, Zhou J, Wu X, Sun Y, et al
    Carvedilol plus NUCs for compensated HBV-cirrhosis patients under virological suppression: a randomised, open-label trial.
    Am J Gastroenterol. 2023 Nov 6. doi: 10.14309/ajg.0000000000002569.
    PubMed         Abstract available

  2. KULKARNI AV, Avadhanam M, Karandikar P, Rakam K, et al
    Antibiotics with or without Rifaximin for acute hepatic Encephalopathy in critically ill patients with cirrhosis: A double-blind, randomized controlled (ARiE) trial.
    Am J Gastroenterol. 2023 Nov 9. doi: 10.14309/ajg.0000000000002575.
    PubMed         Abstract available

  3. BAJAJ JS, Kamath PS, Reddy KR, Asrani SK, et al
    Predictors of Respiratory Failure Development in A Multi-Center Cohort of Inpatients with Cirrhosis.
    Am J Gastroenterol. 2023 Nov 8. doi: 10.14309/ajg.0000000000002574.
    PubMed         Abstract available

  4. PATEL A, Bowman CA, Prause N, Kilaru SM, et al
    Outcomes of a Three-Year Quality Improvement Study to Improve Advance Care Planning in Patients with Decompensated Cirrhosis.
    Am J Gastroenterol. 2023 Nov 7. doi: 10.14309/ajg.0000000000002570.
    PubMed         Abstract available

    Am J Pathol

  5. WARNER JB, Hardesty JE, Song YL, Floyd AT, et al
    Hepatic Transcriptome and Its Regulation Following Soluble Epoxide Hydrolase Inhibition in Alcohol-Associated Liver Disease.
    Am J Pathol. 2023 Nov 2:S0002-9440(23)00410-8. doi: 10.1016/j.ajpath.2023.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  6. JIN Q, Hu Y, Gao Y, Zheng J, et al
    Hhex and Prox1a synergistically dictate the hepatoblast to hepatocyte differentiation in zebrafish.
    Biochem Biophys Res Commun. 2023;686:149182.
    PubMed         Abstract available

  7. JUNG M, Ji E, Kang H, Kim C, et al
    The microRNA-195-5p/hnRNP A1 axis contributes to the progression of hepatocellular carcinoma by regulating the migration of cancer cells.
    Biochem Biophys Res Commun. 2023;686:149183.
    PubMed         Abstract available

  8. HE J, Han J, Lin K, Wang J, et al
    PTEN/AKT and Wnt/beta-catenin signaling pathways regulate the proliferation of Lgr5+ cells in liver cancer.
    Biochem Biophys Res Commun. 2023;683:149117.
    PubMed         Abstract available

  9. QU D, Chen M, Zhu H, Liu X, et al
    Akkermansia muciniphila and its outer membrane protein Amuc_1100 prevent high-fat diet-induced nonalcoholic fatty liver disease in mice.
    Biochem Biophys Res Commun. 2023;684:149131.
    PubMed         Abstract available

    BMC Cancer

  10. ZHANG L, Su K, Liu Q, Li B, et al
    Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study.
    BMC Cancer. 2023;23:1081.
    PubMed         Abstract available

  11. KLEMM S, Evert K, Utpatel K, Muggli A, et al
    Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis.
    BMC Cancer. 2023;23:1086.
    PubMed         Abstract available

  12. WANG J, Peng Y, Jing S, Han L, et al
    A deep-learning approach for segmentation of liver tumors in magnetic resonance imaging using UNet+.
    BMC Cancer. 2023;23:1060.
    PubMed         Abstract available

  13. NAKHARUTAI N, Chitapanarux I, Traisathit P, Srikummoon P, et al
    Prediction of survival and analysis of prognostic factors for hepatocellular carcinoma: a 20-year of imaging diagnosis in Upper Northern Thailand.
    BMC Cancer. 2023;23:1063.
    PubMed         Abstract available

    BMC Gastroenterol

  14. LI S, Feng L, Ding J, Zhou W, et al
    Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
    BMC Gastroenterol. 2023;23:376.
    PubMed         Abstract available

    Br J Surg

  15. Corrigendum to: Variation in treatment of intrahepatic cholangiocarcinoma: a nationwide multicentre study.
    Br J Surg. 2023 Oct 31:znad365. doi: 10.1093.


  16. Erratum to "Association between posttreatment alpha-fetoprotein reduction and outcomes in real-world US patients with advanced hepatocellular carcinoma".
    Cancer. 2023 Nov 4. doi: 10.1002/cncr.35102.

    Clin Res Hepatol Gastroenterol

  17. MUTANEN A, Pakarinen MP
    Featuring molecular regulation of bile acid homeostasis in pediatric short bowel syndrome.
    Clin Res Hepatol Gastroenterol. 2023;47:102220.
    PubMed         Abstract available

  18. ALLAIRE M, Roux C, Akhavan S, Lebray P, et al
    Difficulties in assessing portal hypertension in case of HVB-HVD co infection.
    Clin Res Hepatol Gastroenterol. 2023;47:102213.

  19. BOILLOT O, Guillaud O, Wischlen E, Ruiz M, et al
    Determinants of early surgical complications after pediatric liver transplantation: A single center/single surgeon experience over 20 years.
    Clin Res Hepatol Gastroenterol. 2023;47:102222.
    PubMed         Abstract available

    Dig Dis Sci

  20. JAMES M, Alazawi W
    Non-invasive Tests of Fibrosis: Does One Size Fit All?
    Dig Dis Sci. 2023;68:4285-4286.

  21. ARORA U, Goyal RM, Teh KKJ, Pei Y, et al
    Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: A Multicentric Asian Study.
    Dig Dis Sci. 2023;68:4485-4498.
    PubMed         Abstract available


    Alternatives to animal testing to assess NASH drugs and hepatotoxicity.
    Hepatology. 2023 Nov 6. doi: 10.1097/HEP.0000000000000669.
    PubMed         Abstract available

  23. SELLERS ZM, Assis DN, Paranjape SM, Sathe M, et al
    Cystic fibrosis screening, evaluation and management of hepatobiliary disease consensus recommendations.
    Hepatology. 2023 Oct 26. doi: 10.1097/HEP.0000000000000646.
    PubMed         Abstract available

  24. QASIM KHAN M, Hassan S, Lizaola-Mayo BC, Bhat M, et al
    Navigating the 'Specific Etiology' steatohepatitis category: Evaluation & management of non-alcohol/non-metabolic dysfunction-associated steatohepatitis.
    Hepatology. 2023 Nov 7. doi: 10.1097/HEP.0000000000000674.

  25. LIU N, Tian J, Steer CJ, Han Q, et al
    MicroRNA-206-3p suppresses hepatic lipogenesis and cholesterol synthesis while driving cholesterol efflux.
    Hepatology. 2023 Nov 9. doi: 10.1097/HEP.0000000000000672.
    PubMed         Abstract available

  26. KARVELLAS CJ, Bajaj JS, Kamath PS, Napolitano L, et al
    AASLD Practice guidance on Acute-on-chronic liver failure and the management of critically Ill patients with cirrhosis.
    Hepatology. 2023 Nov 9. doi: 10.1097/HEP.0000000000000671.

    Indian J Gastroenterol

  27. GIRI S, Anand AC
    Non-cirrhotic intrahepatic portal hypertension: Is the gun loaded?
    Indian J Gastroenterol. 2023 Nov 9. doi: 10.1007/s12664-023-01466.

  28. JAIN AK, Bundiwal AK, Jain S, Agrawal P, et al
    Evaluation of liver and splenic stiffness by acoustic radiation force impulse for assessment of esophageal varices.
    Indian J Gastroenterol. 2023 Nov 6. doi: 10.1007/s12664-023-01456.
    PubMed         Abstract available

    J Clin Oncol

  29. WANG G, Zhuo N, Liu Z
    Nonalcoholic Fatty Liver Disease May Be an Independent, Modifiable Risk Factor for Young-Onset Digestive Tract Cancers.
    J Clin Oncol. 2023;41:5070.

    J Gastroenterol

  30. YANG Z, Shi M, Liang Y, Zhang F, et al
    Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus.
    J Gastroenterol. 2023 Nov 5. doi: 10.1007/s00535-023-02053.
    PubMed         Abstract available

    J Hepatol

  31. LIU J, Qian J, Yang Z, Zhou L, et al
    Patients with Hepatocellular carcinoma and portal vein tumour thrombosis after successful downstaging may be candidates for liver transplantation:A meta-analysis.
    J Hepatol. 2023 Nov 6:S0168-8278(23)05231-5. doi: 10.1016/j.jhep.2023.

    J Pediatr

  32. GUPTA PM, Madewell ZJ, Gannon BM, Grahn M, et al
    Hepatic Vitamin A Concentrations and Association with Infectious Causes of Child Death.
    J Pediatr. 2023 Nov 4:113816. doi: 10.1016/j.jpeds.2023.113816.
    PubMed         Abstract available

    J Pediatr Surg

  33. BAUZON J, Froehlich M, Dadon N, Morris D, et al
    Outcomes of Primary Tumor Excision do not Differ from Non-Resection Methods in Pediatric Mesenchymal Hamartoma of the Liver: A Rapid Systematic Review.
    J Pediatr Surg. 2023;58:2356-2361.
    PubMed         Abstract available

  34. YOSRA K, Ghada H, Bochra A, Fatma T, et al
    Predictive Factors of Liver Hydatid Cyst Recurrence in Children.
    J Pediatr Surg. 2023;58:2362-2367.
    PubMed         Abstract available


  35. VON KODOLITSCH Y, Kubisch C, Carrel T
    AATD as a genetic risk factor for aneurysmal disease - Authors' reply.
    Lancet. 2023;402:1626.

    AATD as a genetic risk factor for aneurysmal disease.
    Lancet. 2023;402:1625-1626.


  37. ZHOU J, Xu W, Wu Y, Wang M, et al
    GPR37 promotes colorectal cancer liver metastases by enhancing the glycolysis and histone lactylation via Hippo pathway.
    Oncogene. 2023 Sep 25. doi: 10.1038/s41388-023-02841.
    PubMed         Abstract available

  38. LIU F, Liao Z, Zhang Z
    MYC in liver cancer: mechanisms and targeted therapy opportunities.
    Oncogene. 2023;42:3303-3318.
    PubMed         Abstract available

    PLoS One

  39. YANG H, Meng L, Xin S, Chang C, et al
    Non-linear association between aspartate aminotransferase to alanine aminotransferase ratio and mortality in critically ill older patients: A retrospective cohort study.
    PLoS One. 2023;18:e0293749.
    PubMed         Abstract available

  40. MOON JJ, Hong SK, Kim YC, Hong SY, et al
    Soluble suppression of tumorigenicity 2 is a potential predictor of post-liver transplant renal outcomes.
    PLoS One. 2023;18:e0293844.
    PubMed         Abstract available

    Radiol Imaging Cancer

  41. LIN YM
    Noninferiority in Overall Survival with Thermal Ablation for Treating Small Colorectal Liver Metastases.
    Radiol Imaging Cancer. 2023;5:e239020.


  42. JIANG H, Yang C, Chen Y, Wang Y, et al
    Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection.
    Radiology. 2023;309:e230527.
    PubMed         Abstract available

  43. HSIEH C, Laguna A, Ikeda I, Maxwell AWP, et al
    Using Machine Learning to Predict Response to Image-guided Therapies for Hepatocellular Carcinoma.
    Radiology. 2023;309:e222891.
    PubMed         Abstract available

  44. TSAI R, Mellnick VM
    Using an Imaging Model to Predict Recurrence in Patients with Hepatocellular Carcinoma.
    Radiology. 2023;309:e232480.

  45. OZTURK A, Kumar V, Pierce TT, Li Q, et al
    The Future Is Beyond Bright: The Evolving Role of Quantitative US for Fatty Liver Disease.
    Radiology. 2023;309:e223146.
    PubMed         Abstract available

    Semin Liver Dis

  46. HAN X, Sun Q, Xu M, Zhu G, et al
    Unraveling the Complexities of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.
    Semin Liver Dis. 2023 Nov 6. doi: 10.1055/s-0043-1776127.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.